Short answer
LifeStance Health Group, Inc. (LFST) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $364M (up 16.3% year over year) with net income of $1M.
Q3 2025 key financials · XBRL
- Revenue
- $364M
- +16.3% YoY · +5.4% QoQ
- Net income
- $1M
- +118.1% YoY · +128.4% QoQ
- Operating margin
- 2.0%
Source: XBRL data from the LifeStance Health Group, Inc. (LFST) Q3 2025 10-Q on SEC EDGAR. USD.
LifeStance Health Group, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk: Impact of One Big Beautiful Bill Act (OBBBA) enacted July 4, 2025, with changes to Medicaid renewal and eligibility, effective 2027-2028, currently not materially impacting business
- Updated risk: Payor contract renegotiations may lower reimbursement rates, risking revenue due to dependency on significant payors for patient service revenue
- Legal risk: Ongoing privacy and compensation class action litigations, with litigation costs impacting quarterly expenses including non-recurring charges
- Operational risk: Clinician productivity and recruitment critical to visit volume and revenue growth; employed clinician base grew by 764 clinicians since prior year
- Financial risk: Decreased total revenue per visit (TRPV) due to a single payor rate decrease, partially offset by moderate payor rate increases impacting revenue growth
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LifeStance Health Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.